Wang, Xiao
Peng, Jing
Yang, Ziqiang
Zhou, Pei-Jie
An, Na
Wei, Lianzi
Zhu, Helen He
Lu, Jinsong
Fang, Yu-Xiang
Gao, Wei-Qiang
Funding for this research was provided by:
National Natural Science Foundation of China (81672543, 31401233, 81630073, 81872406)
Ministry of Science and Technology of the People's Republic of China (2017YFA0102900)
Science and Technology Commission of Shanghai Municipality (16JC1405700)
High Peak IV subject on stem cells and translational medicine from Education Commission of Shanghai Municipality
KC Wong foundation
Article History
Received: 12 September 2018
Accepted: 6 January 2019
First Online: 21 January 2019
Ethics approval and consent to participate
: Investigation has been conducted in accordance with the ethical standards and according to the Declaration of Helsinki and national and international guidelines. Human tissues used in this study were reviewed and approved by the Committee for Ethical Review of Research Involving Human Subjects at Ren Ji Hospital. Informed consent was obtained from each patient. All animal studies were performed according to the protocols approved by the Renji Hospital Medical Experimental Animal Care Commission.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.